Munjal Sushil Kumar, Natarajan Sekar, Vinay V, Meenakshisundaram Arunachalam
Department of TB and Respiratory Diseases, National Institute of Tuberculosis and Respiratory Diseases, New Delhi, India.
Department of Pulmonary Medicine, Critical Care and Sleep Medicine, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
J Family Med Prim Care. 2022 Nov;11(11):7267-7271. doi: 10.4103/jfmpc.jfmpc_870_22. Epub 2022 Dec 16.
Hemoptysis presents as a primary complaint in 8-15% of chest clinic patients. The etiology of hemoptysis varies among different series according to the time of publication, geographic location, and diagnostic tests employed.
To study the clinical profile of patients hospitalized with hemoptysis at a tertiary respiratory care center in New Delhi, India.
The study was a cross-sectional, observational, hospital-based study. Patients admitted with hemoptysis in emergency from November 2017 to April 2018 were enrolled. A total of 129 patients were evaluated by a detailed clinical history and necessary investigations deemed required for arriving at the diagnosis. Subjects' hospitalized details were recorded using structured evaluation proforma. Data were evaluated using SPSS version 22.0. The 'p' value of less than 0.05 was considered statistically significant.
A total of 129 patients were recruited, with a mean age of 42.67 years, 59.7% were male. Mild, moderate, severe, and massive hemoptysis were seen in 15.5%, 46.5%, 25.6% and 12.4% cases, respectively. History of pulmonary tuberculosis treatment was present in 40.3%, recurrent hemoptysis in 38% and bilateral chest x-ray involvement in 62.6% cases. Tuberculosis (active and sequelae) was the most common cause (51.9%) of hemoptysis. Recurrent hemoptysis and low hemoglobin were found to be independent risk factors associated with the severity of hemoptysis.
Tuberculosis remains a significant cause of hemoptysis in our country. Even one episode of hemoptysis should not be ignored and investigated properly as it can potentially cause massive hemoptysis and life-threatening complications in the future.
咯血是胸部门诊患者8%-15%的主要主诉。根据发表时间、地理位置和所采用的诊断测试不同,不同系列研究中咯血的病因也有所差异。
研究印度新德里一家三级呼吸护理中心因咯血住院患者的临床特征。
本研究为一项基于医院的横断面观察性研究。纳入2017年11月至2018年4月因咯血急诊入院的患者。通过详细的临床病史和为明确诊断所需的必要检查对总共129例患者进行评估。使用结构化评估表格记录受试者的住院详细信息。数据使用SPSS 22.0版本进行评估。p值小于0.05被认为具有统计学意义。
共招募129例患者,平均年龄42.67岁,男性占59.7%。轻度、中度、重度和大量咯血分别见于15.5%、46.5%、25.6%和12.4%的病例。40.3%的病例有肺结核治疗史,38%有反复咯血史,62.6%的病例双侧胸部X线受累。结核病(活动期和后遗症)是咯血最常见的原因(51.9%)。反复咯血和低血红蛋白被发现是与咯血严重程度相关的独立危险因素。
在我国,结核病仍然是咯血的重要原因。即使是一次咯血发作也不应被忽视,应进行适当检查,因为它未来可能导致大量咯血和危及生命的并发症。